PEJMF (Peijia Medical) Total Operating Expense: $95.9 Mil (TTM As of Dec. 2025)


PEJMF Peijia Medical Ltd PEJMF
74 GF Score
Price $1.39
GF Value $2.57
! 4 Warning Signs
View Full Analysis

What is Peijia Medical Total Operating Expense?

Peijia Medical PEJMF 74 Total Operating Expense is $95.9 Mil as of Dec. 2025. GuruFocus rates PEJMF with a GF Score™ of 74/100 and a GF Value™ of $2.57. The stock has 4 warning signs investors should review.

Peijia Medical's Total Operating Expense for the six months ended in Dec. 2025 was $52.2 Mil. Peijia Medical's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was $95.9 Mil.

Peijia Medical Total Operating Expense Related Terms

Peijia Medical Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Peijia Medical's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peijia Medical Total Operating Expense Chart

Peijia Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 101.31 104.41 103.81 91.19 96.74

Peijia Medical Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.28 42.01 49.34 43.67 52.22
PEJMF
74GF Score
Peijia Medical Ltd PEJMF
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peijia Medical Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $95.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $95.9 Mil mean?
Peijia Medical (PEJMF) has a Total Operating Expense of $95.9 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Peijia Medical and its competitors.
Is Peijia Medical's Total Operating Expense too high?
Peijia Medical's current Total Operating Expense is $95.9 Mil. Overall, Peijia Medical has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's Total Operating Expense compare to ABT and SYK?
Peijia Medical's Total Operating Expense of $95.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Peijia Medical and its competitors. Peijia Medical's current Total Operating Expense is $95.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current Total Operating Expense of $95.9 Mil. The stock's GF Value™ is $2.57, compared to a current price of $1.39 — trading 46% below its estimated fair value. The current Total Operating Expense is $95.9 Mil. Peijia Medical's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current Total Operating Expense is $95.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peijia Medical (PEJMF) Overvalued in 2026?

Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued. The current stock price of $1.39 is trading 46% below its estimated GF Value™ of $2.57.

Key valuation signals for PEJMF:

  • Total Operating Expense: $95.9 Mil
  • GF Value™: $2.57 vs. price of $1.39 (46% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Peijia Medical Business Description

Other Exchanges 09996:Hong Kong4WO:Germany
Address No.18 Yangjiatian Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
74GF Score

Get the complete analysis for PEJMF

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.39
Price
$2.57
GF Value